Detail akcie ResMed online

Business Summary: ResMed Inc. is a holding company. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The Company’s segments include Sleep and Respiratory Care and Software as a Service. SDB includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital software health applications, along with its devices, are designed to provide connected care to improve patient outcomes. Its portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, and cloud-based software and informatics solutions. Its comprehensive out-of-hospital software platforms support the professionals and caregivers.
Financial Summary: BRIEF: For the six months ended 31 December 2023, Resmed Inc revenues increased 14% to $2.27B. Net income decreased 2% to $428.2M. Revenues reflect Sleep and Respiratory Care segment increase of 12% to $1.98B, Software as a Service segment increase of 28% to $284.2M. Net income was offset by Selling, general and administrative increase of 10% to $445M (expense), Research and development increase of 12% to $149.6M (expense).